Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Politics : Formerly About Advanced Micro Devices -- Ignore unavailable to you. Want to Upgrade?

To: longnshort who wrote (456557)	2/14/2009 12:28:14 PM
From: i-node	Respond to of 1574494

This is a train wreck which has great potential for destroying the best health care system in the world. And the truth is, the whole world loses, because they, too are beneficiaries of our great health care system. When the Daschle plan stipulates that we won't pay for, for example, cancer drugs because they're too expensive for the amount of "life" we can extract from them, you kill the incentive for development of new drugs. Under this arrangement, you might never have seen Taxotere developed after Taxol. Because even with Taxol, many patients continued to die. Drugs like Neulasta ($4,500 for 6mg) will probably never see the light of day. Consider Justice Ginsberg, who now faces a very deadly form of Pancreatic cancer. These patients are often dead within weeks or months. Why bother with treatment under this new plan? It never works anyway. Just let her give up without a fight.